Related Experiment Video
Updated: Oct 7, 2025

07:52
A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain
Published on: April 9, 2019
8.8K
Engineered human blood-brain barrier microfluidic model for vascular permeability analyses.
Cynthia Hajal1, Giovanni S Offeddu2, Yoojin Shin2
1Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Nature Protocols
|January 8, 2022
Summary
Researchers developed a novel in vitro human blood-brain barrier (BBB) model using microfluidic devices. This advanced model aids in understanding molecular transport and designing targeted therapies for neurological disorders.
Area of Science:
- Neuroscience
- Biomedical Engineering
- Cell Biology
Background:
- The blood-brain barrier (BBB) impedes drug delivery to the brain.
- Existing animal models show poor translation to human clinical outcomes.
- There is a critical need for in vitro human BBB models for research and therapeutic development.
Purpose of the Study:
- To develop and validate a self-assembled in vitro human blood-brain barrier (BBB) model.
- To provide a platform for assessing molecular transport across the BBB.
- To facilitate the design of targeted therapies for neurological disorders.
Main Methods:
- Fabrication of microfluidic devices for BBB model self-assembly.
- Co-culture of stem-cell-derived or primary brain endothelial cells with primary brain pericytes and astrocytes.
- Assessment of molecular permeability using established methodologies.
- Analysis of cellular organization, morphology, gene, and protein expression.
Main Results:
- The in vitro BBB model demonstrated relevant cellular organization and morphology.
- Molecular permeability values were consistent with in vivo expectations.
- The model exhibited functional brain endothelial expression profiles.
- The protocol allows for rapid permeability measurements with low reagent consumption.
Conclusions:
- The developed microfluidic BBB model offers a robust platform for studying brain barrier function.
- This model overcomes limitations of traditional 2D assays and animal models.
- It is suitable for widespread adoption in academic and industrial research for neurological disorder therapeutics.

